INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 March 2011
|
Total net assets |
£103.6m |
|
NAV per share |
176.2p |
|
Share price |
153.0p |
|
Total value of unquoted investments |
£25.2m |
|
Total number of portfolio companies |
58 |
|
Cash |
(1)% NAV |
|
Cash committed and reserved to unquoted investments |
9% NAV |
|
Portfolio companies with < 1 year of cash |
11% NAV |
Top Ten Holdings
|
Company Name |
% NAV |
|
Shire Ltd |
5.89 |
|
Celgene |
5.88 |
|
Cadent |
5.48 |
|
Gilead Sciences |
5.17 |
|
Amgen |
4.95 |
|
Insulet |
4.74 |
|
Teva |
4.28 |
|
Micromet |
3.49 |
|
Vertex |
3.23 |
|
Alexion |
3.01 |
|
|
----------- |
|
Total |
46.12 |
|
Geographical Allocation |
% |
|
United States |
70 |
|
Europe |
25 |
|
Middle East |
4 |
|
Australia |
2 |
|
Cash |
(1) |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted allocation |
% |
|
Quoted |
77 |
|
Unquoted |
24 |
|
Cash |
(1) |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
20 APRIL 2011